SCHEMBL17875772

SCHEMBL17875772

c1ccc2c(c1)oc1ccc(-c3ccc4c(c3)-c3cc(-n5c6ccccc6c6ccccc65)ccc3CSC4)cc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.34
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
ATM Q13315 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
AHR P35869 1/20 0.31
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
CHEK2 O96017 1/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875743 0.96 SMN1; SMN2 (0.33) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17875716 0.96 SMN1; SMN2 (0.33) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17875774 0.93 ATM (0.34) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17877648 0.89 TNKS (0.33)
SCHEMBL17875715 0.89 PTGER4 (0.34) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17875729 0.89 PTGER4 (0.34) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17875879 0.88 NPC1 (0.35) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17875775 0.87 ALOX5 (0.32) KDM4EATML3MBTL1
SCHEMBL17875792 0.87 MAPT (0.44) SMN1; SMN2KDM4EMEN1NPC1ALDH1A1
SCHEMBL17877824 0.86 TNKS (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 SMN1; SMN2 3237/4885KDM4E 3120/4885MEN1 448/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 SMN1; SMN2 3237/4885KDM4E 3120/4885MEN1 448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.